Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Squamous Cell Lung Cancer × iniparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Squamous Cell Lung Cancer 1 Solid Tumors 1 Breast Neoplasms 1

Interventions

iniparib 1 Gemcitabine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01082549 2016-03-17

ECLIPSE

Sanofi

Phase 3 Completed

Squamous Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡